Gilead Sciences’s (GILD) Kite Announces Yescarta CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. — Black or African American Patients Experienced Longer Time […]